Dr. Avalos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Levine Cancer Institute
1021 Morehead Medical Dr, Suite 5002
Charlotte, NC 28204Phone+1 980-442-2000Fax+1 704-355-5800- Is this information wrong?
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1985 - 1986
Ohio State University HospitalFellowship, Hematology and Medical Oncology, 1984 - 1985- Ohio State University HospitalResidency, Internal Medicine, 1980 - 1983
- Ohio State University College of MedicineClass of 1980
Certifications & Licensure
OH State Medical License 1981 - 2025
NC State Medical License 2012 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- LCI-HEM-SPEC-001: Tissue Collection for Genetic Analysis of Acute Myelogenous Leukemia Start of enrollment: 2013 Nov 01
- Factors Affecting Post-transplant Cyclophosphamide (PTCy) Efficacy Start of enrollment: 2018 Jul 13
Publications & Presentations
PubMed
- Pharmacogenetic and clinical predictors of voriconazole concentration in hematopoietic stem cell transplant recipients receiving CYP2C19-guided dosing.Jai N Patel, Myra Robinson, Sarah A Morris, Elizabeth Jandrisevits, Karine Eboli Lopes, Alicia Hamilton, Nury Steuerwald, Lawrence J Druhan, Belinda Avalos, Edward Cop...> ;The Pharmacogenomics Journal. 2023 Nov 1
- 1 citationsOutcomes and hospitalization patterns of patients with acute myelogenous leukemia treated with frontline CPX-351 or HMA/venetoclax.Aleksander L Chojecki, Justin Arnall, Danielle Boselli, Rushil Patel, Zane Chiad, Kristyn Y DiSogra, Allison Karabinos, Tommy Chen, Adilen Cruz, Allison Verbyla, Jing ...> ;Leukemia Research. 2022 Aug 1
- Optimization of physician and specialty pharmacy clinical workflow in assessment of risk category and symptom burden in patients with myelofibrosis (MF).Aleksander L Chojecki, Kristyn Y DiSogra, Justin Arnall, Nicole Cowgill, Amy Soni, Charles H Packman, Srinivasa Reddy Sanikommu, Nilay A Shah, Brittany K Ragon, Thomas...> ;Leukemia & Lymphoma. 2022 Jun 1
- Join now to see all
Abstracts/Posters
- Patient Reported Financial Toxicity in Myeloproliferative NeoplasmsBelinda R Avalos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Minorities Do Not Have Worse Outcomes for Diffuse Large B Cell Lymphoma (DLBCL) If Optimally ManagedBelinda R Avalos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- New Germline Syndrome Discovery: Heterozygous CSF3R Mutations May Predispose to Myeloid and Lymphoid MalignanciesBelinda R Avalos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Press Mentions
ASH Announces New Executive Committee Members, Hosts MDS+AML MATTER Education Program, and MoreNovember 28th, 2018
Grant Support
- G-CSF Receptor And UbiquitinationNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006
- Loss Of Negative Signaling By The G-CSFR In AMLNational Cancer Institute2000–2002
- Loss Of Negative Signaling By The Gcsfr In AMLNational Cancer Institute1999
- G-CSFR Mutations--A Novel Mechanism Of LeukemogenesisNational Cancer Institute1997–1998
- Human Erythroid-Potentiating ActivityNational Heart, Lung, And Blood Institute1987–1990
- Human Erythroid-Potentiating ActivityNational Heart, Lung, And Blood Institute1986
Committees
- Member, American Society of Hematology Executive Committee 2015 - Present
- Chair, American Society of Hematology, Committee on Promoting Diversity 2014 - Present
Hospital Affiliations
Atrium Health's Carolinas Medical CenterCharlotte, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
